Birgegard, G., Bjorkholm, M., Kutti, J., Larfars, G., Lofvenberg, E., Markevarn, B., Merup, M., Palmblad, J., Mauritzson, N., Westin, J. and Samuelsson, J. (2004) “Adverse effects and benefits of two years of anagrelide treatment for thrombocythemia in chronic myeloproliferative disorders”, Haematologica. Pavia, Italy, 89(5), pp. 520-527. Available at: https://haematologica.org/article/view/3073 (Accessed: 19November2026).